Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aarron T Willingham

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Mechanisms of Development|August 26, 2004
A tissue specific cytochrome P450 required for the structure and function of Drosophila sensory organsAarron T Willingham, Thomas Keil
Cell|July 4, 2006
TUF love for "junk" DNAAarron T Willingham, Thomas R Gingeras
Nature Reviews. Genetics|May 9, 2007
Genome-wide transcription and the implications for genomic organizationPhilipp Kapranov, Aarron T Willingham, Thomas R Gingeras
Oncogene|November 2, 2004
RNAi and HTS: exploring cancer by systematic loss-of-functionAarron T Willingham, Quinn L Deveraux, Garret M Hampton, et al.
Nucleic Acid Therapeutics|April 24, 2012
Adenosine modification may be preferred for reducing siRNA immune stimulationRaymond V Fucini, Henry J Haringsma, Patricia Deng, et al.
Nucleic Acid Therapeutics|March 10, 2012
In vivo activity and duration of short interfering RNAs containing a synthetic 5'-phosphateDenise M Kenski, Aarron T Willingham, Henry J Haringsma, et al.
Nucleic Acids Research|January 19, 2012
mRNA knockdown by single strand RNA is improved by chemical modificationsHenry J Haringsma, Jenny J Li, Ferdie Soriano, et al.
RNA (New York, N.Y.)|August 23, 2012
Single-stranded microRNA mimicsGuillaume Chorn, Molly Klein-McDowell, Lihong Zhao, et al.
Molecular Therapy. Nucleic Acids|January 25, 2013
siRNA-optimized Modifications for Enhanced In Vivo ActivityDenise M Kenski, Gabor Butora, Aarron T Willingham, et al.
Nucleic Acids Research|November 18, 2009
Analysis of acyclic nucleoside modifications in siRNAs finds sensitivity at position 1 that is restored by 5'-terminal phosphorylation both in vitro and in vivoDenise M Kenski, Abby J Cooper, Jenny J Li, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Mechanisms of Development|August 26, 2004
A tissue specific cytochrome P450 required for the structure and function of Drosophila sensory organsAarron T Willingham, Thomas Keil
Cell|July 4, 2006
TUF love for "junk" DNAAarron T Willingham, Thomas R Gingeras
Nature Reviews. Genetics|May 9, 2007
Genome-wide transcription and the implications for genomic organizationPhilipp Kapranov, Aarron T Willingham, Thomas R Gingeras
Oncogene|November 2, 2004
RNAi and HTS: exploring cancer by systematic loss-of-functionAarron T Willingham, Quinn L Deveraux, Garret M Hampton, et al.
Nucleic Acid Therapeutics|April 24, 2012
Adenosine modification may be preferred for reducing siRNA immune stimulationRaymond V Fucini, Henry J Haringsma, Patricia Deng, et al.
Nucleic Acid Therapeutics|March 10, 2012
In vivo activity and duration of short interfering RNAs containing a synthetic 5'-phosphateDenise M Kenski, Aarron T Willingham, Henry J Haringsma, et al.
Nucleic Acids Research|January 19, 2012
mRNA knockdown by single strand RNA is improved by chemical modificationsHenry J Haringsma, Jenny J Li, Ferdie Soriano, et al.
RNA (New York, N.Y.)|August 23, 2012
Single-stranded microRNA mimicsGuillaume Chorn, Molly Klein-McDowell, Lihong Zhao, et al.
Molecular Therapy. Nucleic Acids|January 25, 2013
siRNA-optimized Modifications for Enhanced In Vivo ActivityDenise M Kenski, Gabor Butora, Aarron T Willingham, et al.
Nucleic Acids Research|November 18, 2009
Analysis of acyclic nucleoside modifications in siRNAs finds sensitivity at position 1 that is restored by 5'-terminal phosphorylation both in vitro and in vivoDenise M Kenski, Abby J Cooper, Jenny J Li, et al.
Pageof 2